One R&D Innovation in CSL is driven by its R&D organisation with approximately 2,500 employees located within biotech hubs and precincts in 10 countries around the world that are linked to strong research networks and external collaborations that CSL actively establish and foster. A philosophy of global collaboration underpins CSL’s presence within those research precincts and provides access to worldwide, leading innovation to advance the discovery and development of pioneering biotherapies to address unmet medical needs in CSL’s areas of focus. Innovation Innovation is a critical pillar of CSL’s 2030 strategy. It underpins everything we do, from One R&D, to CSL Plasma centers, to CSL’s manufacturing sites and enterprise-wide digital architecture. 2,500+ R&D employees working in R&D centres located in leading biomedical locations in 10 countries Limited Annual Report 2023/24 26
RkJQdWJsaXNoZXIy MjE2NDg3